Immunovant Shares Drop After Roivant Opts for Strategic Investment

Immunovant Shares Drop After Roivant Opts for Strategic Investment

Source: 
Marketwatch
snippet: 

Immunovant Inc.'s shares fell sharply early Monday after majority shareholder Roivant Sciences Ltd. made a $200 million strategic investment, opting against buying the outstanding minority interest in the clinical-stage biopharmaceutical company.